Effector Therapeutics Inc.  (EFTR)
Other Ticker:  
Price: $0.5641 $-0.00 -0.159%
Day's High: $0.5797 Week Perf: -2.37 %
Day's Low: $ 0.52 30 Day Perf: -10.46 %
Volume (M): 100 52 Wk High: $ 11.95
Volume (M$): $ 56 52 Wk Avg: $3.71
Open: $0.56 52 Wk Low: $0.47

 Market Capitalization (Millions $) 23
 Shares Outstanding (Millions) 41
 Employees -
 Revenues (TTM) (Millions $) 3
 Net Income (TTM) (Millions $) 17
 Cash Flow (TTM) (Millions $) -0
 Capital Exp. (TTM) (Millions $) 0

Effector Therapeutics Inc.

   Company Address: 142 North Cedros Avenue Solana Beach 92075 CA
   Company Phone Number: 925-8215   Stock Exchange / Ticker: NASDAQ EFTR
   EFTR is expected to report next financial results on November 07, 2022.


Stock Performances by Major Competitors

Year to Date Decrease / Increase
• View Complete Report

Gbs Inc.

Severe hit for Gbs Inc in the financial fourth quarter of 2022

In the financial fourth quarter of 2022 Gbs Inc lost money of $-0.14 per share compared to $-0.57 a year ago and increased losses from $-0.09 per share from the previous quarter.

Calamp Corp.

Deficit Bigger Than a Year Ago due Decrease in Demand at Calamp Corp in the second quarter of 2022

Lower demand led to lower revenues and higher loss, in the second quarter of 2022 company loss increased to $-0.21 per share, while Sales fell by -7.83% to $72.83 millions, year on year.

Startech Labs Inc.

Startech Labs Inc announced most recent fiscal period operating shortfall of $-0.0047 millions

In the most recent fiscal period Startech Labs Inc reached break-even of $-0.00 per share compared to $-0.00 a year ago and from $0.00 per share from the previous quarter.

Palatin Technologies Inc.

EPS Fell while Sales More than Doubled

Despite very strong Sales growth of 381.11% year on year to $0.84 millions in the fiscal span ending Jun 30 2022, company faced earnings turn positive at $0.07.

Dynatronics Corporation

Weak Demand Cause for EPS Slide

In the financial fourth quarter of 2022 earnings per share plummeted by -55.89 % to $0.07 per share due to Sales decrease of -8.55% to $11.19 millions, year on year.


Effector Therapeutics's Segments
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

VEEV's Profile

Stock Price

VEEV's Financials

Business Description


Charts & Quotes

VEEV's News


VEEV's Competitors

Customers & Markets

Economic Indicators

VEEV's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries






About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071